| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0037 | 1 |